Table 2 Summary of the results for assessment of the severity of symptoms based on ICIQ‐UI SF, ICIQ‐VS, and QUID

Loohuis et al. [34, 35]

ICIQ-UI-SF

10.3 ± 3.4

9.5 ± 3.2

− 2.6 ± 3.5^a

− 2.2 ± 2.6^a

7.1 ± 4.3

7.0 ± 3.3

Wang et al. [33]

ICIQ-UI SF

6.1 ± 1.5

5.7 ± 1.4

2.0 ± 3.1

1.3 ± 2.9

1.0 ± 2.2

0.7 ± 2.0

0.4 ± 1.4

0.3 ± 1.1

Araujo et al. [31]

ICIQ‐UI SF

15.9 ± 4.7

16.3 ± 4.0

12.4 ± 6.7

12.9 ± 4.6

11.3 ± 5.0

10.9 ± 6.9

9.7 ± 6.6

9.1 ± 6.6

ICIQ‐VS

13.7 ± 8.4

11.8 ± 8.8

10.9 ± 8.1

9.7 ± 8.5

7.0 ± 3.9

6.2 ± 7.9

6.0 ± 4.9

6.8 ± 8.2

QUID

15.6 ± 7.4

14.4 ± 8.3

9.2 ± 6.9

10.4 ± 9.4

4.5 ± 7.1

8.7 ± 9.3

3.9 ± 3.6

7.5 ± 9.0

Jia et al. [32]

ICIQ‐UI SF

8.5 ± 2.3

8.5 ± 2.2

8.0 ± 2.0

4.4 ± 2.0

Asklund et al. [29]

ICIQ-UI SF

11.0 ± 2.6

11.1 ± 3.0

10.2 ± 3.2

7.0 ± 3.5

None

8.1 ± 3.9

Sjöström et al. [27]

ICIQ-UI SF

10.3 ± 3.5

10.4 ± 3.1

7.3 ± 3.9

6.9 ± 3.1

6.7 ± 3.2

6.6 ± 3.1

6.4 ± 3.5

6.5 ± 3.0